Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) versus Budesonide for asthma in children aged 6 to less than…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide (BUDESONIDE)
• QMF149 (Indacaterol Acetate/Mometasone Furoate) (Indacaterol Acetate / Mometasone Furoate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: RECRUITING